misleading statements

Rosen Law Firm filed securities class action against Concorde International Group ($CIGL) alleging fraudulent promotion schemes and insider share dumping. Affected investors must act before critical deadlines.

Snowflake faces securities fraud suit after 18% stock drop on corrective disclosures regarding consumption patterns and $10B revenue target claims.

Alight Inc. faces securities fraud lawsuit after missing guidance twice, with stock falling 18-38%. Shareholders can claim losses through May 2026.

Class action lawsuit filed against $PSIX alleging false statements about data center market capabilities and understated manufacturing costs between May 2025 and March 2026.

Power Solutions International shareholders file class action lawsuit alleging false statements about data center demand and manufacturing inefficiencies, following significant stock declines.

Portnoy Law Firm files class action against $ENPH over alleged misstatements about inventory management and tax credit impacts. Stock falls 15% post-earnings.

$SNOW faces class action lawsuit over alleged misstatements on product efficiency, Iceberg Tables, and storage pricing. Stock fell 18% when revenue headwinds disclosed.

Class action lawsuit filed against $PLUG alleging false statements on DOE funding and hydrogen facilities between January-November 2025. Investors have until April 3, 2026 to seek lead plaintiff status.

Class action lawsuit filed against Ultragenyx Pharmaceutical alleging false statements about setrusumab efficacy for Osteogenesis Imperfecta treatment based on flawed trial comparisons.

Class action lawsuit filed against Eos Energy Enterprises ($EOSE) alleging executives made false statements about production capacity, battery downtime, and quality issues from November 2025 to February 2026.

Class action filed against $EOSE alleging materially false statements and non-disclosure of production delays, battery downtime, and quality control failures.

Rosen Law Firm urges MREO investors to act before April 6, 2026 deadline in securities class action alleging misleading clinical trial statements.

Picard Medical faces securities fraud lawsuit alleging false statements, social media manipulation, and insider share dumping scheme during September-October 2025 period.

Schall Law Firm investigates $NUVB for potential securities violations after revealing 75% treatment discontinuations in oncology therapy, triggering sharp stock decline.

SES AI faces securities investigation after stock plunged 36.8% following March 4 earnings, allegedly due to undisclosed $1.5M shipment delays.

Rosen Law Firm seeks lead plaintiffs in securities class action against Inovio Pharmaceuticals for alleged misstatements on device defects, regulatory prospects, and product timelines. Lead plaintiff deadline: April 7, 2026.

Richtech Robotics faces securities class action after Microsoft denied partnership, stock crashed 20% following 30% surge on alleged false collaboration announcement.

Hagens Berman investigates BellRing Brands ($BRBR) for allegedly misrepresenting sales growth as consumer demand rather than retailer inventory hoarding, leading to a 33% stock crash.

Rosen Law Firm urges PomDoctor investors to join securities class action by April 7, 2026 deadline alleging false statements, social media fraud, and insider share dumping.

Rosen Law Firm notifies $RARE investors of securities class action alleging materially false statements about setrusumab efficacy in Phase III trials, with April 6, 2026 lead plaintiff deadline.